Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa
- PMID: 23622714
- PMCID: PMC3647643
- DOI: 10.3201//EID1903.120246
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa
Abstract
Factors driving the increase in drug-resistant tuberculosis (TB) in the Eastern Cape Province, South Africa, are not understood. A convenience sample of 309 drug-susceptible and 342 multidrug-resistant (MDR) TB isolates, collected July 2008-July 2009, were characterized by spoligotyping, DNA fingerprinting, insertion site mapping, and targeted DNA sequencing. Analysis of molecular-based data showed diverse genetic backgrounds among drug-sensitive and MDR TB sensu stricto isolates in contrast to restricted genetic backgrounds among pre-extensively drug-resistant (pre-XDR) TB and XDR TB isolates. Second-line drug resistance was significantly associated with the atypical Beijing genotype. DNA fingerprinting and sequencing demonstrated that the pre-XDR and XDR atypical Beijing isolates evolved from a common progenitor; 85% and 92%, respectively, were clustered, indicating transmission. Ninety-three percent of atypical XDR Beijing isolates had mutations that confer resistance to 10 anti-TB drugs, and some isolates also were resistant to para-aminosalicylic acid. These findings suggest the emergence of totally drug-resistant TB.
Keywords: MDR TB; Mycobacterium tuberculosis; South Africa; TB; Tuberculosis; XDR-TB; bacteria; extensively drug-resistant tuberculosis; mycobacteria; totally drug resistant TB.
Figures
Similar articles
-
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.PLoS One. 2013 Aug 23;8(8):e70919. doi: 10.1371/journal.pone.0070919. eCollection 2013. PLoS One. 2013. PMID: 24058399 Free PMC article.
-
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep. PLoS Med. 2015. PMID: 26418737 Free PMC article.
-
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23. Tuberculosis (Edinb). 2016. PMID: 26980491
-
Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.BMC Infect Dis. 2020 May 13;20(1):344. doi: 10.1186/s12879-020-05031-5. BMC Infect Dis. 2020. PMID: 32404119 Free PMC article.
-
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Infect Genet Evol. 2012. PMID: 21839855 Review.
Cited by
-
The totally drug resistant tuberculosis (TDR-TB).Int J Clin Exp Med. 2013 Apr 12;6(4):307-9. Print 2013. Int J Clin Exp Med. 2013. PMID: 23641309 Free PMC article. No abstract available.
-
How the threat of antibiotic apocalypse helped a pharmacist find her voice.Can Pharm J (Ott). 2013 May;146(3):151-4. doi: 10.1177/1715163513486864. Can Pharm J (Ott). 2013. PMID: 23795199 Free PMC article. No abstract available.
-
Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India.Indian J Med Res. 2021 Jul;154(1):85-89. doi: 10.4103/ijmr.IJMR_1168_19. Indian J Med Res. 2021. PMID: 34782533 Free PMC article.
-
Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.J Med Chem. 2020 Sep 10;63(17):8917-8955. doi: 10.1021/acs.jmedchem.9b02075. Epub 2020 Apr 20. J Med Chem. 2020. PMID: 32259446 Free PMC article. Review.
-
The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi.Malawi Med J. 2018 Mar;30(1):1-5. doi: 10.4314/mmj.v30i1.1. Malawi Med J. 2018. PMID: 29868151 Free PMC article.
References
-
- World Health Organization, WHO-IUTALD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world (report no. 4) [cited 2008 Apr 30]. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
-
- World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010. Global report on surveillance and response [cited 2010 Jun 26]. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
-
- National Health Laboratory Services. National Institute for Communicable Diseases annual report 2009. [cited 2012 Jan 26]. http://www.nicd.ac.za/assets/files/Annual_report_2009.pdf
-
- Shean KP, Willcox PA, Siwendu SN, Laserson KF, Gross L, Kammerer S, et al. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992–2002. Int J Tuberc Lung Dis. 2008;12:1182–9 . - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources